Featured

Blaming Pharma Won’t Lower Health Care Costs

This week, the USA Today Editorial Board took aim at the pharmaceutical industry in a new piece: Stop …

Read More
Filter posts

Blaming Pharma Won’t Lower Health Care Costs

This week, the USA Today Editorial Board took aim at the pharmaceutical industry in a new piece: Stop …

“Diverse Candidates Can Win If They Can Get the Interview.”

Diversity is gaining more attention among biotech investors and companies alike. At entry level, 50% …

#BIF17: Looking Ahead to 2018 Policy Landscape

The past year has seen a number of important changes in the legislative and policy …

A Discussion on Value at #BIF17

In a recent op-ed, BIO President and CEO Jim Greenwood wrote about a promising trend …

“Invest in What’s Cool. Invest in Science that Matters.”

One reality of the biotech industry that’s often overlooked is that 90% of biotech companies …

#BIF17: Turning the Tide on Antimicrobial Resistance

It’s no secret that antimicrobial resistance (AMR) is one of the most serious public health …